Autolus Therapeutics AUTL
NASDAQ AUTL
$2.24 -0.05 (-2.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Autolus Therapeutics (AUTL) Invested Capital (2017 - 2019)

Analysis

Autolus Therapeutics (AUTL) Invested Capital (2017 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Autolus Therapeutics 594.86 Mn 393.23 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 269.67 Mn
Jun 30, 2019 298.34 Mn
Dec 31, 2018 232.93 Mn
Sep 30, 2018 255.85 Mn
Sep 30, 2017 143.36 Mn